Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David J Inwards

Showing results (91-100 of 179) with videos related to

Pageof 18
Sort By:
American Journal of Hematology|March 1, 2019
Host genetic variation in tumor necrosis factor and nuclear factor-κB pathways and overall survival in mantle cell lymphoma: A discovery and replication studyYucai Wang, Thomas M Habermann, Sophia S Wang, et al.
British Journal of Haematology|August 8, 2006
Absolute lymphocyte count predicts overall survival in follicular lymphomasMustaqeem Siddiqui, Kay Ristow, Svetomir N Markovic, et al.
JCO Oncology Practice|May 20, 2022
Long-Term Health-Related Quality of Life of Autologous Hematopoietic Cell Transplantation Patients and Nontransplant Patients With Aggressive Lymphoma: A Prospective Cohort AnalysisChristopher S Strouse, Melissa C Larson, Shawna L Ehlers, et al.
British Journal of Haematology|June 28, 2017
Clinical heterogeneity of diffuse large B cell lymphoma following failure of front-line immunochemotherapyUmar Farooq, Matthew J Maurer, Carrie A Thompson, et al.
American Journal of Hematology|December 6, 2018
Role of systemic high-dose methotrexate and combined approaches in the management of vitreoretinal lymphoma: A single center experience 1990-2018Alessia Castellino, Jose S Pulido, Patrick B Johnston, et al.
Mayo Clinic Proceedings|February 13, 2004
Therapeutic options in patients with lymphoma and severe liver dysfunctionIrene M Ghobrial, Robert C Wolf, Denise L Pereira, et al.
Transplantation and Cellular Therapy|June 25, 2022
Progression-Free Survival at 24 Months as A Landmark After Autologous Stem Cell Transplant in Relapsed or Refractory Diffuse Large B-cell LymphomaAung M Tun, Seth Maliske, Yucai Wang, et al.
Transplantation and Cellular Therapy|July 12, 2024
Autologous Stem Cell Transplant in Fit Patients With Late Relapsed Diffuse Large B-Cell Lymphoma That Responded to Salvage ChemotherapyAung M Tun, Yucai Wang, Seth Maliske, et al.
Leukemia & Lymphoma|October 27, 2006
The International Prognostic Index predicts outcome after histological transformation of low-grade non-Hodgkin lymphomaIvana N M Micallef, Ellen D Remstein, Stephen M Ansell, et al.
Leukemia & Lymphoma|September 18, 2008
Long-term outcome of allogeneic stem cell transplantation in chronic lymphocytic leukemia: analysis after a minimum follow-up of 5 yearsPankaj Malhotra, William J Hogan, Mark R Litzow, et al.
Pageof 18

Showing results (91-100 of 179) with videos related to

Sort By:
Pageof 18
American Journal of Hematology|March 1, 2019
Host genetic variation in tumor necrosis factor and nuclear factor-κB pathways and overall survival in mantle cell lymphoma: A discovery and replication studyYucai Wang, Thomas M Habermann, Sophia S Wang, et al.
British Journal of Haematology|August 8, 2006
Absolute lymphocyte count predicts overall survival in follicular lymphomasMustaqeem Siddiqui, Kay Ristow, Svetomir N Markovic, et al.
JCO Oncology Practice|May 20, 2022
Long-Term Health-Related Quality of Life of Autologous Hematopoietic Cell Transplantation Patients and Nontransplant Patients With Aggressive Lymphoma: A Prospective Cohort AnalysisChristopher S Strouse, Melissa C Larson, Shawna L Ehlers, et al.
British Journal of Haematology|June 28, 2017
Clinical heterogeneity of diffuse large B cell lymphoma following failure of front-line immunochemotherapyUmar Farooq, Matthew J Maurer, Carrie A Thompson, et al.
American Journal of Hematology|December 6, 2018
Role of systemic high-dose methotrexate and combined approaches in the management of vitreoretinal lymphoma: A single center experience 1990-2018Alessia Castellino, Jose S Pulido, Patrick B Johnston, et al.
Mayo Clinic Proceedings|February 13, 2004
Therapeutic options in patients with lymphoma and severe liver dysfunctionIrene M Ghobrial, Robert C Wolf, Denise L Pereira, et al.
Transplantation and Cellular Therapy|June 25, 2022
Progression-Free Survival at 24 Months as A Landmark After Autologous Stem Cell Transplant in Relapsed or Refractory Diffuse Large B-cell LymphomaAung M Tun, Seth Maliske, Yucai Wang, et al.
Transplantation and Cellular Therapy|July 12, 2024
Autologous Stem Cell Transplant in Fit Patients With Late Relapsed Diffuse Large B-Cell Lymphoma That Responded to Salvage ChemotherapyAung M Tun, Yucai Wang, Seth Maliske, et al.
Leukemia & Lymphoma|October 27, 2006
The International Prognostic Index predicts outcome after histological transformation of low-grade non-Hodgkin lymphomaIvana N M Micallef, Ellen D Remstein, Stephen M Ansell, et al.
Leukemia & Lymphoma|September 18, 2008
Long-term outcome of allogeneic stem cell transplantation in chronic lymphocytic leukemia: analysis after a minimum follow-up of 5 yearsPankaj Malhotra, William J Hogan, Mark R Litzow, et al.
Pageof 18